TYR and melanoma: Twenty-six patients with stage III melanoma and 19 with stage IV melanoma were treated with intranodal infusion of a monocyte-derived mature DC vaccine pulsed with gp100 and tyrosinase mRNA by electroporation; antigen-specific T-cell immunoreactivity was observed in 17 of the 26 patients in stage III melanoma.